These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21403399)

  • 21.
    Hu J; Li S; Sun X; Fang Z; Wang L; Xiao F; Shao M; Ge L; Tang F; Gu J; Yu H; Guo Y; Guo X; Liao B; Jin Y
    J Biol Chem; 2019 Jun; 294(25):9959-9972. PubMed ID: 31092598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
    Li DQ; Ohshiro K; Reddy SD; Pakala SB; Lee MH; Zhang Y; Rayala SK; Kumar R
    Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17493-8. PubMed ID: 19805145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
    Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
    Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling.
    Nateri AS; Riera-Sans L; Da Costa C; Behrens A
    Science; 2004 Feb; 303(5662):1374-8. PubMed ID: 14739463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
    Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
    Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Arabidopsis SUMO E3 Ligase, SIZ1, Negatively Regulates Photomorphogenesis by Promoting COP1 Activity.
    Lin XL; Niu D; Hu ZL; Kim DH; Jin YH; Cai B; Liu P; Miura K; Yun DJ; Kim WY; Lin R; Jin JB
    PLoS Genet; 2016 Apr; 12(4):e1006016. PubMed ID: 27128446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
    Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
    Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.
    Yoshida A; Kato JY; Nakamae I; Yoneda-Kato N
    Blood; 2013 Sep; 122(10):1750-60. PubMed ID: 23884858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
    Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
    Subramanian D; Bunjobpol W; Sabapathy K
    J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
    Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
    Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity.
    Bianchi E; Denti S; Catena R; Rossetti G; Polo S; Gasparian S; Putignano S; Rogge L; Pardi R
    J Biol Chem; 2003 May; 278(22):19682-90. PubMed ID: 12615916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spotlight on the role of COP1 in tumorigenesis.
    Marine JC
    Nat Rev Cancer; 2012 Jun; 12(7):455-64. PubMed ID: 22673153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.
    Zhang Y; Yokoyama S; Herriges JC; Zhang Z; Young RE; Verheyden JM; Sun X
    Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7557-62. PubMed ID: 27335464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
    Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
    Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice.
    Sancho R; Nateri AS; de Vinuesa AG; Aguilera C; Nye E; Spencer-Dene B; Behrens A
    EMBO J; 2009 Jul; 28(13):1843-54. PubMed ID: 19521338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.